Concepedia

Publication | Open Access

CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure

151

Citations

15

References

2020

Year

Abstract

Monthly repeated dosing of CDR132L is safe and adequate to provide clinically relevant exposure and therapeutic efficacy in a model of chronic post-MI HF. CDR132L thus should be explored as treatment for the broad area of chronic heart failure.

References

YearCitations

Page 1